Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Show more
Location: 3052 Orchard Drive, San Jose, CA, 95134, United States | Website: https://www.outsetmedical.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
220.8M
52 Wk Range
$5.85 - $25.35
Previous Close
$12.43
Open
$12.47
Volume
286,988
Day Range
$12.16 - $13.06
Enterprise Value
139M
Cash
184.1M
Avg Qtr Burn
-16.89M
Insider Ownership
2.68%
Institutional Own.
88.58%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|